CPS Research   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Glasgow United Kingdom (1988)

Organization Overview

First Clinical Trial
2006
NCT00397189
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Community Pharmacology Services Ltd | CPSResearch | CPS Research

Active Ingredients

Drugs in Phase 4 Trials (1)

escitalopram (lexapro) (1 trial)

Drugs in Phase 3 Trials (1)

melatonin (1 trial)

Drugs in Phase 2 Trials (4)

amitriptyline (elavil) (1 trial)

citalopram (celexa) (1 trial)

pipamperone (1 trial)

tramadol (Ultram) (1 trial)

Drugs in Other Trials (2)

bifidobacterium animalis (1 trial)

metronidazole (flagyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8